Evidence map›Paper›PMID 41814337›Full record

ArticleMolecular brain2026

PKMζ-KIBRA interactions, molecular turnover, and memory.

Changchi Hsieh, David A Cano, Panayiotis Tsokas, James E Cottrell, André Antonio Fenton, Harel Shouval, Todd Charlton Sacktor

Abstract read
In one paragraph

Article in Molecular brain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Changchi Hsieh *Department of Physiology and Pharmacology, The Robert F. Furchgott Center for Neural and Behavioral Science, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.
David A Cano *College of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.
Panayiotis TsokasDepartment of Physiology and Pharmacology, The Robert F. Furchgott Center for Neural and Behavioral Science, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.
James E CottrellDepartment of Anesthesiology, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.
André Antonio FentonDepartment of Physiology and Pharmacology, The Robert F. Furchgott Center for Neural and Behavioral Science, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.
Harel ShouvalDepartment of Neurobiology and Anatomy, University of Texas Medical at Houston, Houston, TX, 77030, USA. harel.shouval@uth.tmc.edu.
Todd Charlton SacktorDepartment of Physiology and Pharmacology, The Robert F. Furchgott Center for Neural and Behavioral Science, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA. tsacktor@downstate.edu.

Funding

Towards a critical test of the synaptic plasticity and memory hypothesisR01MH132204 · NIMH · NEW YORK UNIVERSITY · PI ANDRE ANTONIO FENTON · 2023 to 2026
$2.5M
Neural coordination and discoordination in Fmr1 null miceR01NS105472 · NINDS · NEW YORK UNIVERSITY · PI FENTON, ANDRE ANTONIO · 2017 to 2021
$1.8M
NIMH NIH HHS R01 MH132204NIMH NIH HHS R37 MH057068, R01 MH115304NINDS NIH HHS R01 NS105472
6 · The paper itself

Abstract

How can the molecules that strengthen synaptic connections maintain memory in the face of molecular turnover? Our previous work showed that persistent interaction between the postsynaptic scaffolding protein, KIBRA, and the autonomously active PKC isoform, PKMζ, is crucial for maintaining synaptic long-term potentiation (LTP) and memory lasting at least a month. This duration is longer than the lifespans of individual KIBRA and PKMζ molecules. Biophysical modeling of the interaction suggests oligomers of KIBRA-PKMζ dimers, but not individual dimers or monomers, can overcome molecular turnover by continuously incorporating newly synthesized KIBRA and PKMζ, replacing those that have degraded. Here we used AlphaFold 3 to predict the structures of KIBRA-PKMζ heterodimers and heterohexamers and to examine the sites of action of two different inhibitors of KIBRA-PKMζ interaction that disrupt established late-LTP and long-term memory. The structures predict that the peptide K-ZAP blocks formation of heterodimers, whereas the small molecule ζ-stat prevents PKMζ of one heterodimer from binding a second KIBRA and PKMζ, essential for forming larger oligomeric structures. We show that ζ-stat, like K-ZAP, disrupts 1-month-old spatial memory. Thus, continuous formation of KIBRA-PKMζ oligomers can be a core molecular mechanism driving the persistence of long-term memory in the face of molecular turnover.

Indexed as

Intracellular Signaling Peptides and ProteinsMemoryPhosphoproteinsProtein Kinase CAnimalsLong-Term PotentiationModels, MolecularProtein BindingProtein Kinase C zetaProtein MultimerizationIntracellular Signaling Peptides and ProteinsPhosphoproteinsProtein Kinase CProtein Kinase C zetaprotein kinase M zeta, ratlong-term potentiation (LTP)PKM-zetaPKMzetaWWC1

Identifiers

PMID41814337
PMCPMC12997682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.